Why the body defends its weight — set point and compensatory mechanisms

The body weight set point is a concept describing body weight as a homeostatically regulated parameter — defended by the body much like temperature or blood pressure. According to this model, the brain seeks to keep weight within a defined range and activates compensatory mechanisms whenever weight deviates from it. This is the physiological explanation for why weight loss is often hard to maintain and why the weight “comes back”.

This article is educational in nature and constitutes a review of the published scientific literature on the physiology of body weight regulation. It is not medical or dietary advice, nor a nutrition plan. It describes regulatory mechanisms, not recommendations for action. Some of the data cited comes from human studies and some from models — this distinction is flagged throughout.

What the set point is — body weight as a defended value

In the classical physiological view, the body regulates many parameters around a certain set point: body temperature around 37°C, blood glucose within a narrow range, blood pressure. The body weight set point theory extends this logic to weight: it assumes there is a “defended” weight value towards which the regulatory system strives, correcting deviations in both directions.

Evidence for such regulation comes from both observations and experiments. After deliberate overfeeding that leads to weight gain, the body usually increases energy expenditure and reduces appetite, seeking to return to the baseline value. After deliberate weight loss the opposite occurs: appetite rises and energy expenditure falls. In both directions, the system “pulls” weight back towards its previous level.

It is worth flagging a limitation of this model at the outset. Some researchers prefer the notion of a settling point — a point of equilibrium that is not a rigidly encoded value but the net result of genetic, hormonal and environmental factors. On this view, the “defended” weight may drift over time, particularly in an environment abundant in energy-dense food. Whichever terminology is chosen, the core point is the same: body weight is actively regulated, not the passive outcome of simple arithmetic.

The mechanism of weight defence — leptin, the hypothalamus and the energy-reserve signal

At the heart of this regulation lies the axis between adipose tissue and the brain. Adipose tissue is not a passive store — it secretes leptin, a hormone whose concentration is roughly proportional to the amount of stored fat. Leptin acts as a signal informing the brain about the state of energy reserves.

The hypothalamus, and the arcuate nucleus in particular, receives this signal and integrates it with others (ghrelin from the stomach, incretins from the gut, neural signals). On this basis it regulates two levers: appetite (how much the body wants to eat) and energy expenditure (how much energy it uses). When energy reserves are high, a high leptin level suppresses appetite. When reserves fall, a low leptin level intensifies hunger and lowers expenditure.

This explains why the defence of weight is asymmetrical and especially strong against weight loss. From an evolutionary standpoint, an energy deficit was historically more dangerous than an energy surplus, so the mechanisms defending against weight loss are stronger than those limiting weight gain. The body “fights” to return to its previous level of reserves more vigorously when it loses them than when it gains them.

Why the defended level tends to rise over time

If the body defends a particular weight, why does body weight increase over the years in many people? The answer lies precisely in the asymmetry of regulation combined with the environment. The mechanism defending against weight gain is weaker than the one defending against weight loss — and in an environment abundant in energy-dense, readily available food, the weaker “upper barrier” tends to be breached systematically.

In the settling point model, this means that the point of equilibrium may gradually shift upwards: the body “accepts” a new, higher level of reserves and over time begins to defend it as it did the previous one. A phenomenon described as leptin resistance emerges — despite a high leptin concentration (proportional to large fat reserves), the brain stops effectively perceiving its satiety signal, as though reserves were lower than they actually are. The mechanism of leptin resistance is explored in a separate piece on leptin and ghrelin.

An important conclusion for understanding the whole picture follows from this: the “defended” weight is not a constant given for life. It is dynamic and sensitive to the environment, yet its drift is asymmetrical — it shifts upwards more readily than downwards. This explains why a spontaneous return to a lower weight is physiologically difficult, and why interventions acting on the regulation itself are the subject of intensive research.

Why the weight comes back — the persistence of hormonal adaptations

The most practical manifestation of the set point at work is the tendency to regain lost weight. The mechanism behind this phenomenon has been documented in studies on the hormonal consequences of weight reduction.

The classic work of Leibel et al. showed that after weight loss, energy expenditure falls more than would follow from the reduction in body weight alone — the body becomes “energetically thriftier” (Leibel et al., 1995). Later studies showed that the hormonal changes accompanying weight loss — a decrease in leptin and a rise in ghrelin and other appetite-stimulating hormones — persist for a long time after dieting ends, rather than only during it (Sumithran et al., 2011). The body long “remembers” its higher weight and signals a drive to regain it.

In this light, regaining weight after a diet is not evidence of a lack of discipline but a predictable consequence of the physiological defence of the defended level. This is a shift in perspective of considerable scientific significance: it describes regulation, it does not judge the person.

Can the defended weight shift — the boundary science is probing

Since the body defends a particular weight level, a scientific question arises: can this level be shifted downwards, rather than merely dropping temporarily below it against the resistance of the regulatory system? This question lies at the foundation of part of the research on metabolic pharmacology.

In scientific publications and in materials popularising knowledge about the treatment of obesity (including National Geographic and works devoted to obesity treatment), GLP-1 receptor agonists are described as acting on the same hypothalamic regulatory system that defends the set point. In clinical trials of these substances, not only weight loss was observed but also its maintenance at a reduced level for the duration of therapy — which is sometimes interpreted as a pharmacological effect on the “defended” weight value, rather than merely a temporary drop below it (research context: Wilding et al., 2021).

The above is an account of hypotheses and research observations concerning medicines used under medical supervision (e.g. semaglutide as Wegovy). It is not advice, a recommendation or a suggestion to use any substance for the purpose of weight reduction. The interpretation of “lowering the set point” remains a subject of research, not an established clinical fact.

This mechanism is scientifically important because it distinguishes interventions acting “against” the regulation (classic restriction, which the body opposes) from interventions acting “on the regulation itself”. A fuller picture of the hormonal regulation of appetite is developed in the pieces on leptin and ghrelin and on the gut–brain axis in this knowledge base.

State of the research — an overview

A shared conclusion: weight loss triggers a coherent, predictable set of defensive responses. Importantly, most of the observations cited come from human studies, which strengthens their explanatory value. Understanding these mechanisms is a description of physiology, not guidance for action.

Research reagents in the area of body weight regulation

The mechanisms of body weight regulation are a subject of research on metabolic pharmacology. The substances analysed in this context — GLP-1 receptor agonists and related compounds — are available in the One-Peptides catalogue as research reagents, including semaglutide (a GLP-1 monoagonist) and retatrutide (a triple agonist). These are chemical reagents intended solely for laboratory research (Research Use Only) — not medicines, supplements or products for human use. The broader context of incretin pharmacology is set out in the guide to GLP-1 peptides and metabolism.

Frequently asked questions

What is the body weight set point?
It is a concept describing body weight as a homeostatically regulated value defended by the body. According to this model, the brain seeks to keep weight within a defined range and activates compensatory mechanisms (changes in appetite and energy expenditure) whenever weight deviates from it. Some researchers use the related notion of a settling point, emphasising the role of the environment.

Why does the weight come back after a diet?
After weight loss the body defends its previous level: energy expenditure falls more than would follow from the weight loss alone, and the hormonal changes that intensify hunger (a decrease in leptin, a rise in ghrelin) persist for a long time after dieting ends. This is a predictable effect of the physiological defence of weight, documented in studies (Leibel 1995; Sumithran 2011).

What role does leptin play in weight regulation?
Leptin is a hormone secreted by adipose tissue in an amount proportional to fat reserves. It informs the brain about the state of energy reserves. A decrease in leptin (with weight loss) intensifies appetite and lowers energy expenditure — one of the main signals in the defence of body weight.

Can the set point be lowered?
This is a research question. In studies of GLP-1 receptor agonists, maintenance of reduced weight was observed during therapy, which is sometimes interpreted as an effect on the body weight regulatory system. This remains a subject of research and relates to medicines used under medical supervision — it is not advice or a recommendation.

Does regaining weight mean a lack of willpower?
In light of physiology — no. Regaining weight after reduction is a predictable consequence of the compensatory mechanisms defending the defended weight level. Studies describe it as biological regulation, not a matter of character.

What is leptin resistance in the context of the set point?
It is a state in which the brain stops effectively perceiving the leptin signal — despite its high concentration, proportional to large fat reserves, the appetite-regulating centres behave as though reserves were lower. This favours the defence of a higher body weight and makes its spontaneous reduction more difficult. The mechanism of leptin resistance is explored in a separate piece on leptin and ghrelin.

Does everyone have the same set point?
No. The defended weight level depends on genetic, hormonal and environmental factors, so it differs between people. Moreover, in a given person it may change over time — it shifts upwards more readily than downwards, particularly in an environment abundant in energy-dense food.

Summary

• The set point is a model describing body weight as a homeostatically defended value; the related notion of a settling point emphasises the influence of the environment.
• The defence of weight is carried out by the adipose tissue–brain axis: leptin signals energy reserves, and the hypothalamus regulates appetite and expenditure.
• The defence is asymmetrical — stronger against weight loss, which explains the tendency to regain it.
• After weight loss, expenditure falls more than the change in weight alone would predict, and the hormonal changes persist for a long time (Leibel 1995; Sumithran 2011).
• Whether the defended weight can be lowered pharmacologically is a research question — analysed, among others, in the context of GLP-1 agonists, as an account of research, not a recommendation.

This content is educational in nature and constitutes a review of the published scientific literature on the physiology of body weight regulation. It does not constitute medical or dietary advice, nor a nutrition plan; it does not serve to diagnose or treat. References to medicines of the GLP-1 agonist class (e.g. semaglutide) concern substances used under medical supervision and are an account of research — they are not a recommendation or a suggestion to use them. Products in the One-Peptides catalogue are chemical reagents intended solely for laboratory research (Research Use Only), not medicines or products for consumption. Decisions regarding body weight and health should be discussed with a doctor or dietitian.

Bibliography

1. Leibel RL, Rosenbaum M, Hirsch J (1995). Changes in energy expenditure resulting from altered body weight
2. Sumithran P et al. (2011). Long-term persistence of hormonal adaptations to weight loss
3. Rosenbaum M, Leibel RL (2010). Adaptive thermogenesis in humans
4. Speakman JR et al. (2011). Set points, settling points and some alternative models: theoretical options to understand how genes and environments combine to regulate body adiposity
5. Wilding JPH et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP-1)

Bartosz BartczakPhysiotherapist, Personal Trainer

Physiotherapist with 20 years of clinical experience, graduate of Poznan University of Medical Sciences. Founder of One Peptides and lead author of clinical-perspective content.

See Full Bio ›